Insulin Glargine in Type 2 Diabetes

Open Trial of the Safety and Efficacy of Lantus for Insulin Naive Type 2 Diabetes Mellitus Patients or Patients Who Use Insulin Combined With 1 or More Oral Antidiabetic Drugs and Don't Have Good Glycemic Control.

The aim of this project is to confirm the efficacy and safety profile of Insulin glargine in daily practice and to improve the physicians' knowledge and experience concerning Insulin glargine

Inclusion Criteria:

• Type 2 Diabetes Mellitus patients,
• Diabetic patients receiving insulin or patients who are insulin-naive and whose glycemic control cannot be sufficiently maintained with single or combined oral antidiabetic agents,
• Patients with HbA1C>8
• Patients able to self-measure its blood glucose levels.

Exclusion Criteria:

• According to package insert information (Summary of Product Characteristics)